[Monoclonal gammapathy: when does the hematologist need the neurologist's help?]
Véronique Leblond1, Marie Anne Hospital, Andréa Toma
1Hématologie, 47 boulevard de l'Hôpital Paris 75013. veronique.leblond@psl.aphp.fr
Bulletin De L'Academie Nationale De Medecine
|February 3, 2010
Summary
Monoclonal immunoglobulins can cause peripheral neuropathy, impacting conditions like POEMS syndrome. Hematologists and neurologists must collaborate to diagnose and treat these complex cases effectively.
Area of Science:
- Hematology
- Neurology
- Immunology
Context:
- Monoclonal immunoglobulins are associated with various hematological disorders, including Waldenstrom's macroglobulinemia, AL amyloidosis, and POEMS syndrome.
- Peripheral neuropathy is a significant clinical manifestation in patients with these conditions.
- The interplay between abnormal immunoglobulin production and neurological damage requires specialized evaluation.
Purpose:
- To outline the diagnostic and therapeutic considerations for patients presenting with both monoclonal immunoglobulins and peripheral neuropathy.
- To emphasize the critical role of interdisciplinary collaboration between hematologists and neurologists.
- To define the distinct responsibilities of each specialist in managing these complex cases.
Summary:
- Hematologists are responsible for characterizing the specific hematological disorder, assessing the need for intervention, and selecting appropriate treatments.
- Neurologists must identify the type of neuropathy and determine its relationship to the abnormal immunoglobulin.
- Effective management hinges on a coordinated approach, integrating hematological expertise with neurological assessment.
Impact:
- Improved diagnostic accuracy for patients with monoclonal gammopathies and neuropathy.
- Optimized treatment strategies leading to better patient outcomes.
- Enhanced understanding of the pathophysiology linking immunoglobulin disorders and peripheral nerve damage.
